The impact of telemedicine on pediatric type 1 diabetes management: benefits, challenges, and future directions
2024

The Impact of Telemedicine on Pediatric Type 1 Diabetes Management

Sample size: 1704 publication 10 minutes Evidence: moderate

Author Information

Author(s): Esposito Susanna, Sambati Vanessa, Fogliazza Federica, Street Maria Elisabeth, Principi Nicola

Primary Institution: Pediatric Clinic, University Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy

Hypothesis

How does telemedicine affect the management of pediatric type 1 diabetes?

Conclusion

Telemedicine can improve pediatric type 1 diabetes care by increasing patient-provider interactions, but its impact on glycemic control is inconsistent.

Supporting Evidence

  • Studies show high levels of patient and provider satisfaction with telemedicine.
  • Telemedicine reduces travel burdens and associated costs for families.
  • Some studies indicate significant reductions in HbA1c levels with telemedicine use.

Takeaway

Telemedicine helps kids with diabetes by making it easier for them to talk to their doctors without going to the clinic, but it doesn't always help their blood sugar levels get better.

Methodology

A comprehensive literature review was conducted using the MEDLINE/PubMed database, covering studies published from January 2000 to May 15, 2024.

Potential Biases

Concerns over privacy and data security due to shared platforms.

Limitations

Methodological limitations include inconsistent randomization strategies and lack of long-term follow-up.

Participant Demographics

The review included studies involving children and adolescents with type 1 diabetes, with a mean age of 13.5 years.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI –0.33 to –0.10

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fendo.2024.1513166

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication